When the Damage Runs Ahead of the Symptoms

The blood test comes back normal. The GP is satisfied; there is nothing to treat. Yet something is off — recovery after exercise takes longer than it should, concentration dips mid-afternoon, and a general flatness has settled in that a holiday does not quite fix. Most people in their forties or fifties will recognise the pattern. Very few will connect it to their inflammatory chemistry.

The difficulty is structural. Standard NHS panels apply CRP reference ranges designed to detect acute illness: anything below 3 mg/L is flagged as acceptable. But research consistently identifies a sub-clinical zone between 1 and 3 mg/L where low-grade, chronic inflammation accumulates silently — no redness, no fever, no diagnosis — while quietly accelerating biological ageing and eroding the resilience that underlies energy, recovery and cognitive sharpness. Because the threshold is set too broadly, a reading of 2.8 mg/L passes unremarked.

This is precisely the gap that the Chemistry pillar of Professor Paul Lee's Regeneration by Design framework addresses. Default health surveillance is calibrated for disease detection; designed longevity requires a different standard. The question is which markers, read at which thresholds, can make the invisible visible — before the damage compounds further.

Inflammaging: What It Is and Why It Accelerates

Think of the immune system as a thermostat. In youth, it spikes to fight a threat, resolves the response, and returns to baseline. Inflammaging — a portmanteau coined to describe the chronic, low-grade, sterile inflammation that accompanies ageing — is what happens when the thermostat jams a few degrees above zero and never fully resets.

This is not the redness and heat of a sprained ankle. There is no obvious trigger and no resolution: just a persistent, smouldering immune activation that generates cellular wear rather than repair. Research from the PolSenior study, tracking more than 3,496 adults aged 65 and over, found that IL-6 — a central cytokine of this process — rose systematically with age even in individuals carrying no diagnosed cardiovascular, metabolic, or cognitive disease. The ageing immune system, it appears, does not need an illness to become overactive.

What drives it? The principal levers sit squarely within the Chemistry and Biology pillars of Regeneration by Design: visceral adiposity, gut permeability, disrupted sleep, sedentary behaviour, oxidative stress, and — critically — dietary pattern. Data from 35,360 postmenopausal women in the Women's Health Initiative confirmed that pro-inflammatory eating is directly associated with measurable shifts in CRP, TNF-αR2, and triglycerides, reinforcing that these are adjustable inputs, not fixed biological sentences.

The distinction is worth holding clearly: inflammation itself is not the problem — it is a necessary repair signal. Chronic, unresolved inflammation, stuck on and generating noise instead of signal, is what degrades the internal environment in which every other pillar of health operates.

hs-CRP and IL-6: The Cytokine Pair Worth Watching

Of the five markers covered here, hs-CRP is the most immediately actionable — not because it is the most upstream signal, but because it sits at the precise fault line between routine medicine and precision longevity monitoring.

Hs-CRP measures the same acute-phase protein as standard CRP, synthesised in the liver in response to IL-6 secretion from macrophages and T cells. The difference is assay sensitivity. Standard CRP tests bottom out at around 3–5 mg/L — adequate for detecting acute infection but too coarse to resolve the sub-clinical zone. High-sensitivity CRP can distinguish down to fractions of a milligram per litre, and that resolution matters: the longevity-relevant risk zone sits between 1 and 3 mg/L, where cardiovascular and biological ageing signals accumulate without triggering a clinical flag.

A reading of 2.4 mg/L is normal by NHS reference standards. By the standards of longevity-focused monitoring, it warrants attention. The optimal target appears to be below 1 mg/L — a threshold most routine panels will never report. The Regen PhD Blood Panel specifies hs-CRP rather than standard CRP precisely for this reason: the higher-resolution test captures the window that conventional screening was not designed to see.

IL-6 sits a step further upstream in the causal chain. As the cytokine that directly triggers hepatic CRP production, it may be elevated for days before CRP rises — making it an earlier signal when the inflammatory cascade is only just beginning to build. Monitoring both together provides two complementary vantage points on the same process: IL-6 as the active driver, hs-CRP as the downstream readout once the signal has registered. The practical constraint is assay cost, which makes IL-6 better suited to comprehensive panels than to routine screening; where it is included, it adds meaningful mechanistic depth to what hs-CRP alone can show.

Fibrinogen and Homocysteine: Vascular Signals Beyond the Usual Panel

Fibrinogen operates at the crossroads of clotting and immune response. Produced by the liver, it is both the protein that forms blood clots and an acute-phase reactant — meaning its levels rise during active systemic inflammation. Chronically elevated fibrinogen therefore carries a dual warning: it flags inflammatory burden and, independently, signals increased cardiovascular risk. Comprehensive clinical frameworks for inflammatory marker assessment include it alongside CRP and serum amyloid A precisely because it captures a dimension of vascular stress that cytokine-focused tests may not.

Homocysteine arrives by a different route. It is not a cytokine but a metabolite — produced from methionine, an amino acid found in dietary protein — and its elevation maps directly onto endothelial damage. When homocysteine accumulates, its metabolite homocysteine thiolactone generates N-homocysteinylated proteins: cytotoxic, proinflammatory, prothrombotic molecules that promote atherosclerosis and arterial stiffness. The evidence for its prognostic significance is striking: in the Ludwigshafen Risk and Cardiovascular Health Study, patients in the highest homocysteine quartile carried a hazard ratio of 2.77 (95% CI 2.28–3.37) for all-cause mortality over a median 9.9-year follow-up, compared with those in the lowest quartile.

What makes homocysteine particularly useful in a systemic monitoring framework is that elevated levels correlate with shorter telomere length, higher IL-6, and higher hs-CRP — placing it at a convergence point across multiple ageing pathways simultaneously. That overlap reinforces the Regeneration by Design principle that no single marker tells the whole story; the Chemistry pillar's signals read most clearly when assessed together.

On intervention: B vitamins — folate, B6, and B12 — can reduce circulating homocysteine, and addressing elevation in high-risk individuals may support vascular health. Randomised trial evidence has not, however, established that lowering homocysteine consistently reduces hard cardiovascular endpoints across unselected populations. Current evidence points towards a precision approach, targeting individuals with confirmed elevation rather than broad supplementation.

Ferritin: The Ageing Marker Most People Overlook

Ferritin is a name most people encounter in one context: a GP flagging levels that are too low and recommending iron supplements. That association — ferritin equals anaemia risk — is clinically useful but incomplete. The less-told story runs in the opposite direction.

At chronically elevated levels, ferritin signals something distinct from deficiency: iron overload, heightened oxidative stress, and active inflammatory burden. A 2024 review confirms that blood ferritin characterises both chronological and biological ageing, directly linking raised levels to ferroptosis — an iron-dependent form of programmed cell death in which excess iron catalyses the oxidative destruction of cell membranes. Where the previous four markers reflect cytokine cascades, vascular stress, or metabolic damage, ferritin traces a parallel but converging pathway: the quiet accumulation of oxidative and iron-homeostasis disruption that also accelerates biological ageing.

As with hs-CRP and the others, the clinical reference range was designed to exclude frank pathology rather than to identify optimal ageing biology. Levels that register as unremarkable on a standard panel may still fall in a range associated with heightened oxidative burden when viewed through a longevity-monitoring lens.

Ferritin earns its place as the fifth marker precisely because it widens the picture beyond cytokines. Together, the five — hs-CRP and IL-6 (cytokine-driven signalling), fibrinogen (clotting and vascular stress), homocysteine (metabolic endothelial damage), and ferritin (oxidative and iron overload) — map the Chemistry pillar's inflammatory landscape across four distinct but interacting mechanisms. No single one is sufficient; all five together begin to tell a coherent story.

Turning Your Numbers Into Action

The five markers are most powerful read as a constellation. A single elevated hs-CRP on its own is unspecific — it could reflect a passing infection or a poor night's sleep. A pattern of sub-optimal hs-CRP alongside raised homocysteine, borderline ferritin, and elevated fibrinogen, tracked across two or three panels, begins to describe a trajectory. That trajectory is where the signal lives.

The Regen PhD Blood Panel was built around this principle: 32 biomarkers across six systems, explicitly including hs-CRP alongside ApoB, Lp(a), and HOMA-IR — markers that standard NHS screening routinely bypasses. It is the Chemistry-pillar tool designed to see what disease-screening was never designed to find.

The evidence for shifting these markers converges on four levers:

• Diet (Chemistry): anti-inflammatory eating patterns — broadly Mediterranean in character, low in ultra-processed food — are associated with meaningful reductions in CRP and related markers.
• Movement (Physics): consistent aerobic activity lowers systemic inflammatory burden and influences ferritin regulation through improved iron metabolism.
• Sleep and stress (Biology): chronic disruption of either elevates cytokine output, including IL-6, measurably and persistently.
• Mindset (Time): in the Health and Retirement Study of 6,099 adults, negative self-perceptions of ageing correlated with higher IL-6 and hs-CRP independent of chronological age. Psychology, it turns out, reaches the Chemistry pillar directly.

The AA:EPA ratio and HbA1c provide supplementary depth for readers who want it — mapping tissue omega-6:omega-3 balance and glycation-driven inflammation respectively — and are worth including in a comprehensive panel.

Several of these five markers sitting at the upper edge of 'normal' simultaneously may mean the body is ageing faster than the calendar suggests. Shifting two of them meaningfully over twelve months — through food, consistent movement, and sleep — is the kind of compound, system-level change that Professor Paul Lee's Regeneration by Design framework is built to support. Chemistry does not move in isolation; but it does move.

The information in this article is for general wellness and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Please consult a qualified healthcare professional for any health concerns.

1. [1] Interleukin-6 and C-reactive protein, successful ageing, and mortality: the PolSenior study. (2016). https://doi.org/10.1186/s12979-016-0076-x https://doi.org/10.1186/s12979-016-0076-x
2. [2] Inflammaging – Wikipedia. https://en.wikipedia.org/?curid=59830296 https://en.wikipedia.org/?curid=59830296
3. [3] The Prospective Relationship Between Subjective Ageing and Inflammation – Health and Retirement Study. (2022). https://doi.org/10.1111/psyp.14177 https://doi.org/10.1111/psyp.14177
4. [4] C-reactive protein – Wikipedia. https://en.wikipedia.org/?curid=307809 https://en.wikipedia.org/?curid=307809
5. [5] Ferritin as a Biomarker of Ageing: Geroprotective Peptides of Standardised Human Placental Hydrolysate (2024 review). (2024). https://doi.org/10.26442/00403660.2024.08.202811 https://doi.org/10.26442/00403660.2024.08.202811
6. [6] Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality – Ludwigshafen Risk and Cardiovascular Health Study. (2019). https://doi.org/10.1007/s00394-019-01993-8 https://doi.org/10.1007/s00394-019-01993-8
7. [7] Homocysteine in the Cardiovascular Setting: What to Know, What to Do, and What Not to Do (2025). (2025). https://doi.org/10.3390/jcdd12100383 https://doi.org/10.3390/jcdd12100383
8. [8] Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular Disease (2025). (2025). https://doi.org/10.3390/ijms26020746 https://doi.org/10.3390/ijms26020746